Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Trinity Biotech PLC

TRIB ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Micro Cap Analyst: N/A

Last Close

$11.67

▼ -1.10%

Market Cap $7.88M · Vol 1.90K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$7.88M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

60.02

Momentum

Beta

1.00

vs Market

52W High

$58.95

80.20% below

52W Low

$8.40

39.01% above

Volume

1.90K

Avg 2.99K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

83.42%

Public shares

Shariah Compliance8 STANDARDS

✗ Trinity Biotech PLC (TRIB) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does TRIB pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-6.11%

+14.41%

-33.36%

-49.48%

YTD

-50.82%

-79.63%

-89.15%

-96.45%

Financials & Valuation

TTM · Annual

Total Revenue	$43.79M
Net Income	$-37,376,000.00
Revenue Growth (YoY)	-30.18%
Gross Margin	38.57%
Operating Margin	-26.07%
Net Profit Margin	-85.36%
ROE	N/A
ROA · ROIC	-35.67% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	0.01
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	13.50M

Technical Indicators

50-Day SMA	$13.12
200-Day SMA	$20.75
RSI (14)	60.02
Beta	1.00
52-Week High	$58.95
52-Week Low	$8.40

Volume Today	1.90K
Avg Daily Volume (30D)	2.99K
Relative Volume	0.63x
Volatility (10D)	114.91
Volatility (30D)	138.84
Free Float	83.42%

Analyst Consensus

N/A

Current Price $11.67

Mean Target N/A

52W Low$8.40 52W High$58.95

Current

Target

$8.40 $58.95

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001S67CN4

ISINUS8964385046

CountryIreland

Sub-IndustryLaboratory Diagnostic & Testing Substances

Earnings DateN/A

TypeStocks

Instrument TypeADR American Depositary Receipt

Similar Halal Stocks

GH Guardant Health Inc -1.46% BIM.PA Biomerieux SA +0.14% TXG 10X Genomics Inc -3.54% LNTH Lantheus Holdings Inc +0.01% CAI Caris Life Sciences Inc -1.71%

Company Profile

Trinity Biotech plc is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemical parameters in serum, plasma and whole blood, and the Company intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its TrinScreen Human Immunodeficiency Virus (HIV) rapid point-of-care test is a high-quality, single-use immunoassays to aid in the diagnosis of HIV. The Uni-Gold range of rapid point-of-care test devices consist of high-quality, single-use immunoassays to aid in the diagnosis of HIV.